Almazroo OA, Miah MK, Venkataramanan R (2017) Drug metabolism in the liver. Clin Liver Dis 21(1):1–20

Article  PubMed  Google Scholar 

Amano K, Leung PS, Rieger R et al (2005) Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174(9):5874–5883

Article  CAS  PubMed  Google Scholar 

Andrade RJ, Chalasani N, Bjornsson ES et al (2019) Drug-induced liver injury. Nat Rev Dis Primers 5(1):58

Article  PubMed  Google Scholar 

Anklam E, Bahl MI, Ball R et al (2022) Emerging technologies and their impact on regulatory science. Exp Biol Med (Maywood) 247(1):1–75

Article  CAS  PubMed  Google Scholar 

Baudy AR, Otieno MA, Hewitt P et al (2020) Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 20(2):215–225

Article  CAS  PubMed  Google Scholar 

Bell CC, Hendriks DF, Moro SM et al (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6(1):25187

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bell CC, Lauschke VM, Vorrink SU et al (2017) Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury. Drug Metab Dispos 45(4):419–429

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bircsak KM, DeBiasio R, Miedel M et al (2021) A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate(R). Toxicology 450:152667

Article  CAS  PubMed  Google Scholar 

Boul M, Benzoubir N, Messina A et al (2021) A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation. Sci Rep 11(1):14075

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canet MJ, Hardwick RN, Lake AD et al (2015) Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis. Drug Metab Dispos 43(2):266–272

Article  PubMed  PubMed Central  Google Scholar 

Carmichael PL, Baltazar MT, Cable S et al (2022) Ready for regulatory use: NAMs and NGRA for chemical safety assurance. Altex 39(3):359–366

PubMed  Google Scholar 

Chiang JYL, Ferrell JM (2018) Bile acid metabolism in liver pathobiology. Gene Expr 18(2):71–87

Article  CAS  PubMed  PubMed Central  Google Scholar 

Darnell M, Schreiter T, Zeilinger K et al (2011) Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor. Drug Metab Dispos 39(7):1131–1138

Article  CAS  PubMed  Google Scholar 

de Bruijn VMP, Wang Z, Bakker W, Zheng W, Spee B, Bouwmeester H (2022) Hepatic bile acid synthesis and secretion: comparison of in vitro methods. Toxicol Lett 365:46–60

Article  PubMed  Google Scholar 

Dingemanse J, van Giersbergen PL (2004) Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. Clin Pharmacokinet 43(15):1089–1115

Article  CAS  PubMed  Google Scholar 

Docci L, Milani N, Ramp T et al (2022) Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies. Lab Chip 22(6):1187–1205

Article  CAS  PubMed  Google Scholar 

Donato MT, Gallego-Ferrer G, Tolosa L (2022) In vitro models for studying chronic drug-induced liver injury. Int J Mol Sci. 23:11428. https://doi.org/10.3390/ijms231911428

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duivenvoorde LPM, Louisse J, Pinckaers NET, Nguyen T, van der Zande M (2021) Comparison of gene expression and biotransformation activity of HepaRG cells under static and dynamic culture conditions. Sci Rep 11(1):10327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ehrlich A, Duche D, Ouedraogo G, Nahmias Y (2019) Challenges and opportunities in the design of liver-on-chip microdevices. Annu Rev Biomed Eng 21:219–239

Article  CAS  PubMed  PubMed Central  Google Scholar 

Einarsson C, Ellis E, Abrahamsson A, Ericzon BG, Bjorkhem I, Axelson M (2000) Bile acid formation in primary human hepatocytes. World J Gastroenterol 6(4):522–525

CAS  PubMed  PubMed Central  Google Scholar 

Evangelakos I, Heeren J, Verkade E, Kuipers F (2021) Role of bile acids in inflammatory liver diseases. Semin Immunopathol 43(4):577–590

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fattinger K, Funk C, Pantze M et al (2001) The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69(4):223–231

Article  CAS  PubMed  Google Scholar 

Fritsche K, Ziková-Kloas A, Marx-Stoelting P, Braeuning A (2023) Metabolism-disrupting chemicals affecting the liver: screening, testing, and molecular pathway identification. Int J Mol Sci. 24:2686. https://doi.org/10.3390/ijms24032686

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerets HH, Tilmant K, Gerin B et al (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28(2):69–87

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gijbels E, Vinken M (2019) Mechanisms of drug-induced cholestasis. Methods Mol Biol 1981:1–14

Article  CAS  PubMed  Google Scholar 

Gijbels E, Vilas-Boas V, Deferm N et al (2019) Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol 93(5):1169–1186

Article  CAS  PubMed  Google Scholar 

Gijbels E, Vilas-Boas V, Annaert P, Vanhaecke T, Devisscher L, Vinken M (2020) Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol 94(4):1151–1172

Article  CAS  PubMed  Google Scholar 

Gijbels E, Devisscher L, Vinken M (2021) Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals. Food Chem Toxicol 152:112165

Article  CAS  PubMed  Google Scholar 

Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315–1530

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL (2021) Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 18(4):252–268

Article  PubMed  Google Scholar